Silence Therapeutics plc (SLN)
NASDAQ: SLN · Real-Time Price · USD
17.83
+0.15 (0.85%)
At close: Nov 4, 2024, 4:00 PM
17.14
-0.69 (-3.87%)
Pre-market: Nov 5, 2024, 9:00 AM EST

Silence Therapeutics Income Statement

Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Revenue
17.925.3817.512.425.480.24
Upgrade
Revenue Growth (YoY)
-37.44%44.99%40.97%126.59%2145.49%-
Upgrade
Cost of Revenue
7.810.3210.887.463.76-
Upgrade
Gross Profit
10.115.066.624.961.720.24
Upgrade
Selling, General & Admin
19.5320.6419.6120.0113.989.64
Upgrade
Research & Development
39.0544.0335.6130.7720.2113.34
Upgrade
Other Operating Expenses
-----1.49-
Upgrade
Operating Expenses
58.5764.6655.2150.7732.722.98
Upgrade
Operating Income
-48.48-49.6-48.59-45.81-30.98-22.73
Upgrade
Interest Expense
--0.03-0.05-0.01-0.02-0.03
Upgrade
Interest & Investment Income
2.780.070.020.010.130.03
Upgrade
Currency Exchange Gain (Loss)
-2.12-2.121.05-0.04-5.17-0.13
Upgrade
Other Non Operating Income (Expenses)
1.381.380.2---
Upgrade
EBT Excluding Unusual Items
-46.43-50.31-47.37-45.86-36.04-22.87
Upgrade
Pretax Income
-46.43-50.31-47.37-45.86-36.04-22.87
Upgrade
Income Tax Expense
-6.33-7.04-6.88-6.45-3.49-3.29
Upgrade
Net Income
-40.1-43.27-40.49-39.41-32.55-19.58
Upgrade
Net Income to Common
-40.1-43.27-40.49-39.41-32.55-19.58
Upgrade
Shares Outstanding (Basic)
423732302725
Upgrade
Shares Outstanding (Diluted)
423732302725
Upgrade
Shares Change (YoY)
18.35%15.21%8.58%8.78%8.85%6.85%
Upgrade
EPS (Basic)
-0.96-1.17-1.26-1.33-1.19-0.78
Upgrade
EPS (Diluted)
-0.96-1.17-1.26-1.33-1.19-0.78
Upgrade
Free Cash Flow
-29.14-39.4-45.65.5-11.291.72
Upgrade
Free Cash Flow Per Share
-0.70-1.06-1.420.19-0.410.07
Upgrade
Gross Margin
56.40%59.34%37.83%39.94%31.34%100.00%
Upgrade
Operating Margin
-270.81%-195.48%-277.66%-369.02%-565.49%-9317.21%
Upgrade
Profit Margin
-224.01%-170.51%-231.35%-317.44%-594.03%-8025.41%
Upgrade
Free Cash Flow Margin
-162.76%-155.25%-260.53%44.26%-206.00%704.10%
Upgrade
EBITDA
-48.16-49.27-48.28-45.56-30.49-22.25
Upgrade
EBITDA Margin
-269.02%-194.18%-275.89%---
Upgrade
D&A For EBITDA
0.320.330.310.250.50.48
Upgrade
EBIT
-48.48-49.6-48.59-45.81-30.98-22.73
Upgrade
EBIT Margin
-270.81%-195.48%-277.66%---
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.